Pharmaniaga Berhad

KLSE:PHARMA Stok Raporu

Piyasa değeri: RM 547.7m

Pharmaniaga Berhad Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Zulkifli Bin Jafar

İcra Kurulu Başkanı

RM 168.6k

Toplam tazminat

CEO maaş yüzdesi83.1%
CEO görev süresiless than a year
CEO sahipliğin/a
Yönetim ortalama görev süresi1.3yrs
Yönetim Kurulu ortalama görev süresi2.5yrs

Son yönetim güncellemeleri

Recent updates

Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry

Jul 18
Pharmaniaga Berhad's (KLSE:PHARMA) Shares Bounce 25% But Its Business Still Trails The Industry

Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S

May 09
Why Investors Shouldn't Be Surprised By Pharmaniaga Berhad's (KLSE:PHARMA) Low P/S

Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate

Apr 19
Pharmaniaga Berhad (KLSE:PHARMA) Shares Could Be 49% Below Their Intrinsic Value Estimate

Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price

Oct 03
Insufficient Growth At Pharmaniaga Berhad (KLSE:PHARMA) Hampers Share Price

Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?

Jul 19
Is There An Opportunity With Pharmaniaga Berhad's (KLSE:PHARMA) 37% Undervaluation?

Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?

Feb 18
Is It Too Late To Consider Buying Pharmaniaga Berhad (KLSE:PHARMA)?

Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital

Dec 10
Many Would Be Envious Of Pharmaniaga Berhad's (KLSE:PHARMA) Excellent Returns On Capital

Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts

Nov 24
Bullish: Analysts Just Made A Massive Upgrade To Their Pharmaniaga Berhad (KLSE:PHARMA) Forecasts

We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings

Aug 27
We Think That There Are Issues Underlying Pharmaniaga Berhad's (KLSE:PHARMA) Earnings

Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet

May 28
Pharmaniaga Berhad (KLSE:PHARMA) Has A Somewhat Strained Balance Sheet

CEO Tazminat Analizi

Zulkifli Bin Jafar'un ücretlendirmesi Pharmaniaga Berhad'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-RM 56m

Mar 31 2024n/an/a

-RM 57m

Dec 31 2023RM 169kRM 140k

-RM 80m

Sep 30 2023n/an/a

-RM 667m

Jun 30 2023n/an/a

-RM 654m

Mar 31 2023n/an/a

-RM 655m

Dec 31 2022RM 1mRM 800k

-RM 630m

Sep 30 2022n/an/a

RM 100m

Jun 30 2022n/an/a

RM 164m

Mar 31 2022n/an/a

RM 177m

Dec 31 2021RM 145kn/a

RM 172m

Sep 30 2021n/an/a

RM 80m

Jun 30 2021n/an/a

RM 32m

Mar 31 2021n/an/a

RM 28m

Dec 31 2020RM 61kn/a

RM 27m

Tazminat ve Piyasa: Zulkifli 'nin toplam tazminatı ($USD 38.21K ), MY pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 109.59K ).

Tazminat ve Kazançlar: Zulkifli 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Zulkifli Bin Jafar (52 yo)

less than a year

Görev süresi

RM 168,569

Tazminat

Encik Zulkifli Bin Jafar is the Managing Director at Pharmaniaga Berhad since September 1, 2024 and serves as its Deputy Chief Executive Officer since February 22, 2023 and was its Executive Director since...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Zulkifli Bin Jafar
Deputy CEO & Managing Directorless than a yearRM 168.57kVeri yok
Norai'ni Binti Mohamed Ali
Chief Financial Officer12.4yrsVeri yokVeri yok
Ahmad Shahredzuan Mohd Shariff
COO & Directorless than a yearRM 136.05kVeri yok
Badarulhisam Rahman
Chief Scientific Officer1.8yrsVeri yokVeri yok
Abdul Mohamed
Executive Vice President of Logistics & Distribution Divisionno dataVeri yokVeri yok
Zulhazri bin Razali
Executive Vice President of Commercial Divisionno dataVeri yokVeri yok
Wan Intan Wan Ismail
Executive VP of Corporate Governance & Company Secretary5yrsVeri yokVeri yok
Azni Basri
Chief People Officerless than a yearVeri yokVeri yok
Idham Ismail
Chief Strategy Officerno dataVeri yokVeri yok
Mohd Ishak
Acting Head of Manufacturing Operationsless than a yearVeri yokVeri yok
Fazleena Jasin
Head of Sustainabilityno dataVeri yokVeri yok
Syaruzaimi Yusof
Company Secretary5yrsVeri yokVeri yok

1.3yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim: PHARMA 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.3 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Zulkifli Bin Jafar
Deputy CEO & Managing Directorless than a yearRM 168.57kVeri yok
Ahmad Shahredzuan Mohd Shariff
COO & Director1.8yrsRM 136.05kVeri yok
Ahmad Bakar
President Director of PT Millennium Pharmacon International Tbk4.3yrsVeri yokVeri yok
Yves Champey
Member of Board Advisory Panelno dataVeri yokVeri yok
Izaddeen Bin Daud
Non-Independent Director3.7yrsRM 192.81kVeri yok
Mohd Bin Zahur Hussain
Independent Non Executive Directorless than a yearRM 40.00kVeri yok
V. Navaratnam
Member of Board Advisory Panelno dataVeri yokVeri yok
Musa bin Mohamad
Chairman of Board Advisory Panelno dataVeri yokVeri yok
Piero Olliaro
Member of Board Advisory Panelno dataVeri yokVeri yok
Sarah binti Abdul Samat
Independent & Non-Executive Director3.3yrsRM 181.67kVeri yok
Abdul Bin Jaafar
Independent Non Executive Chairmanless than a yearVeri yokVeri yok
Abdul Bin Ahmad
Senior Independent & Non-Executive Director4yrsRM 190.04kVeri yok

2.5yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: PHARMA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.5 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.